Aktieanalyser från populära analyshus

Senaste aktieanalyserna

Senzime (Q3 Initial take): Slightly softer sales than expected, but EBIT in line - Redeye

Analys | Redeye

•

Igår 10:25

Senzime (Q3 Initial take): Slightly softer sales than expected, but EBIT in line - Redeye

Senzime

Analys | Analysguiden

•

Igår 09:47

Hanza: Riskprofil har varit bättre - Analysguiden

Hanza ökade omsättningen med 27 procent till 1 401 mkr, varav 2 procent organiskt.

Hanza

Analys | ABG Sundal Collier

•

Igår 09:34

Svedbergs Group Q3: 12% EBITA growth, all segments contribute - ABG

Arise (Q3 Preview): Updated production estimates - Redeye

Redeye updates its production estimates for Arise ahead of its Q3 report, which is due on 6 November...

Aspo: Several transactions have reshaped the company - Nordea

Taaleri: Fair value shifts led Q3 outcomes - Nordea

Taaleri's Q3 results came in clearly above our expectations on a group level, and performance on the...

Truecaller (Q3 Review): Soft quarter, strong foundation - Redeye

Truecaller

Analys | ABG Sundal Collier

•

Igår 07:16

Nolato: No drama, just solid delivery - ABG

* More margin gains, 12% target now looking conservative * Adj.

Nolato

Analys | Analysguiden

•

Igår 07:15

VAXXA: Fortsatt marginalpress men stärkt kassa - Analysguiden

Vaxxa

Analys | ABG Sundal Collier

•

I förrgår 15:44

Nolato: Slight beat on adj. EBITA - ABG

* Adj. EBITA SEK 274m (+4% vs. ABG, +2% vs. IR consensus) * We expect consensus adj.

Marimekko: Expecting strong development - Evli

Oriola: Growth in place, profitability next - Evli

Oriola saw solid growth in Q2, and we anticipate a continued good growth pace in Q3.

Truecaller (Q3 Initial take): Softer than expected - Redeye

Annexin (Q3’25 Review): Clinical study in focus - Redeye

Redeye comments on Annexin’s Q3 report and recent events.

Taaleri: Fair value changes as the main driver in Q3 - Nordea

Nitro Games (Q3 Review): Balancing a soft market with new business optionality - Redeye

Redeye updates on Nitro Games after Q3-results which came in above our expectations owing to solid p...

Heliospectra (Q3 Review): Building the foundation for growth in 2026 and beyond - Redeye

Heliospectra

Analys | Analysguiden

•

27 Oct 16:39

Fastpartner: Ett lägre räntenetto lyfter förvaltningsresultatet - Analysguiden

Fastpartners hyresintäkter och driftnetto minskade för det tredje kvartalet drivet av avyttringar sa...

Fastpartner

Analys | Analysguiden

•

27 Oct 15:11

Beijer Alma: Stark organisk tillväxt och förbättrade marginaler - Analysguiden

Beijer Alma

Analys | Analysguiden

•

27 Oct 15:10

Eastnine: Ett nytt förvärv verkar komma allt närmare - Analysguiden

Eastnine levererar för det tredje kvartalet en stark rapport med rekordresultat.

Polygiene Group (Q3 Review): Recovery in Sight - Redeye

Solteq: Expecting recovery after weaker H1 - Evli

Solteq will report Q3 results this Wednesday, October 29.

Consti: Performance reflects weaker market - Evli

Aspo: ESL earnings recover from here - Evli

Aspo reports Q3 results on Nov 3. In our view the midpoint of FY’25 comparable EBITA guidance remain...

Fable Media Group: Dividend Cap Removed - Redeye

Guard Therapeutics: Phase IIb study POINTER ends in failure - Redeye

Redeye comments on the disappointing news that Guard Therapeutics' drug candidate RMC-035 did not me...

Nitro Games (Q3 Initial take): Stronger than expected - Redeye

Stille (Q3 update): Prolonged headwind but valuation remains undemanding - Redeye

Redeye provides an updated view of Stille following the Q3 2025 report.

Lagercrantz (Q2 review): Strong M&A pipeline - Redeye

Lifco (Q3 review): The flywheel keeps spinning - Redeye

Redeye updates its estimates and valuation after Lifco’s Q3 2025 report.

Lifco

Föregående Nästa